Intellia Therapeutics, Inc. SEC filings NTLA
Intellia Therapeutics, Inc. has 721 filings in SEC EDGAR's recent list, going back to Sep 3, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 3 | Initial insider ownership | Oct 28, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 144 | Notice of proposed sale | Oct 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Sep 4, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 22, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 2, 2026 |
| 144 | Notice of proposed sale | Jul 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 15, 2026 | Jun 13, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Apr 30, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| 424B5 | Prospectus supplement | Apr 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 424B5 | Prospectus supplement | Apr 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 10, 2026 | Apr 7, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 424B5 | Prospectus supplement | Mar 2, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 2, 2026 | Mar 2, 2026 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 3, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 144 | Notice of proposed sale | Dec 11, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2025 | Nov 8, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 4, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 27, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 25, 2025 | Sep 25, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jul 25, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 16, 2025 | Jun 15, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| S-8 | Employee stock plan registration | Jun 11, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2025 | May 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 7, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 21, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 3 | Initial insider ownership | Jan 23, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 8, 2025 | — |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 16, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 25, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 4, 2024 | Oct 2, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 3 | Initial insider ownership | Jul 24, 2024 | Jul 22, 2024 |
| S-8 | Employee stock plan registration | Jul 18, 2024 | — |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 26, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 3 | Initial insider ownership | Jun 17, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2024 | Jun 12, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| 3 | Initial insider ownership | Apr 22, 2024 | Apr 10, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Agreement ended
|
Mar 22, 2024 | Mar 19, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 424B5 | Prospectus supplement | Feb 26, 2024 | — |
| 424B5 | Prospectus supplement | Feb 23, 2024 | — |
| 8-K |
Current report
Material agreement
|
Feb 23, 2024 | Feb 23, 2024 |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 1, 2024 | Jan 31, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| 4 | Insider transaction | Jan 10, 2024 | Jan 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 8, 2024 | — |
| 144 | Notice of proposed sale | Jan 8, 2024 | — |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 144 | Notice of proposed sale | Dec 7, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2023 | Dec 5, 2023 |
| S-3ASR | Automatic shelf registration | Nov 24, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NTLA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1652130
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.